Nov 12 (Reuters) - Peptonic Medical AB PMED.TE :
* PEPTONIC MEDICAL AB CLOSES ITS ISRAELI SUBSIDIARY
* PEPTONIC MEDICAL AB - DECISION WILL RESULT IN SIGNIFICANT
COST
SAVINGS
* PEPTONIC MEDICAL AB: CLOSING MANUFACTURING UNIT WILL LEAD
TO
SIGNIFICANT COST SAVINGS STARTING IN Q1 OF 2025
* PEPTONIC MEDICAL AB - CLOSURE OF SUBSIDIARY IS EXPECTED TO
HAVE
A MINOR NEGATIVE IMPACT ON PEPTONIC'S RESULTS
* PEPTONIC MEDICAL AB - AN EXTERNAL CONTRACT MANUFACTURER IS
NOW
INTENDED TO BE CONTRACTED FOR PRODUCTION OF ITS SELF-DIAGNOSTIC
TESTS
* PEPTONIC MEDICAL AB - PEPTONIC WILL RETAIN KEY ASSETS FROM
ACQUISITION, INCLUDING U.S.-BASED COMMON SENSE
Source text: ID:nWkr57ZlCD
Further company coverage: PMED.TE
((Reuters.Briefs@thomsonreuters.com;;))